RAMP1 — RAMP1 (receptor-activity-modifying protein 1)

RAMP1 (RAMP1 (receptor-activity-modifying protein 1)) is a lever-L3 non-opioid analgesic target. Its promoter reads γ = 1.4249, placing it on the firing-threshold scale at |hsp| = 0.654673; the intervention direction is to block CGRP receptor signalling. The read is reproducible [V]; the clinical magnitude is open [O].

RAMP1 is read from its human promoter by the same deterministic engine used across the map (nearest-neighbour stacking energy → γ = 1.4249; R19 scale → |hsp| = 0.654673). The read places the gene in lever L3; its selectivity is cited Layer-2 biology, and every clinical magnitude (potency, dose, efficacy, safety) is graded [O].

The read

RAMP1 — RAMP1 (receptor-activity-modifying protein 1) sits in the threshold map at γ = 1.4249, |hsp| = 0.654673 (barrier 0.507585). It belongs to lever L3; the intervention direction is to block CGRP receptor signalling (RAMP specificity component).

selectivity (cited) confers CGRP specificity on CLR

burden Tier-1 migraine

Grades

Firewall. γ here is a read of promoter switch-threshold structure only — never this channel's activation voltage, a candidate's potency, a dosing quantity, an in-vivo selectivity, or a clinical effect. Those magnitudes are [O] open.

Source

McLatchie 1998 Nature 393:333 · reproduce the read (engine)

See also: its lever · prioritisation · grading.